STAGE III PANCREATIC NEUROENDOCRINE TUMOR AJCC V8
Clinical trials for STAGE III PANCREATIC NEUROENDOCRINE TUMOR AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PANCREATIC NEUROENDOCRINE TUMOR AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III PANCREATIC NEUROENDOCRINE TUMOR AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo attack on rare pancreatic cancer
Disease control Recruiting nowThis early-stage trial is testing the safety and best dose of combining two targeted cancer drugs for people with advanced pancreatic neuroendocrine tumors (PNETs). One drug blocks signals that help tumors grow, while the other delivers radiation directly to cancer cells. Researc…
Matched conditions: STAGE III PANCREATIC NEUROENDOCRINE TUMOR AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Can a pill cocktail stop this rare cancer from coming back?
Disease control Recruiting nowThis study is testing whether taking two chemotherapy drugs (capecitabine and temozolomide) after surgery can prevent or delay the return of a rare type of pancreatic cancer called a neuroendocrine tumor in high-risk patients. About 141 adults who have recently had their tumor su…
Matched conditions: STAGE III PANCREATIC NEUROENDOCRINE TUMOR AJCC V8
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC